Retavase - 24477-040-01 - (reteplase)

Alphabetical Index


Drug Information of Retavase

Product NDC: 24477-040
Proprietary Name: Retavase
Non Proprietary Name: reteplase
Active Ingredient(s):    & nbsp;   reteplase
Administration Route(s):
Dosage Form(s): KIT
Coding System: National Drug Codes(NDC)

Labeler Information of Retavase

Product NDC: 24477-040
Labeler Name: EKR Therapeutics, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103786
Marketing Category: BLA
Start Marketing Date: 19961030

Package Information of Retavase

Package NDC: 24477-040-01
Package Description: 1 KIT in 1 BOX (24477-040-01) * 10 mL in 1 VIAL * 10 mL in 1 VIAL

NDC Information of Retavase

NDC Code 24477-040-01
Proprietary Name Retavase
Package Description 1 KIT in 1 BOX (24477-040-01) * 10 mL in 1 VIAL * 10 mL in 1 VIAL
Product NDC 24477-040
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name reteplase
Dosage Form Name KIT
Route Name
Start Marketing Date 19961030
Marketing Category Name BLA
Labeler Name EKR Therapeutics, Inc.
Substance Name
Strength Number
Strength Unit
Pharmaceutical Classes

Complete Information of Retavase


General Information